Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 7, 1999, Pages 1049-1054

  Cramer, Hagen ^a   Player, Mark R ^a   Torrence, Paul F ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; RIBONUCLEASE H;

ARTICLE; ENZYME ACTIVATION; METHYLATION; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; RNA DEGRADATION; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ADENINE NUCLEOTIDES; BASE SEQUENCE; ENDORIBONUCLEASES; HYDROLYSIS; METHYLATION; OLIGONUCLEOTIDES, ANTISENSE; OLIGORIBONUCLEOTIDES; RIBONUCLEASE H, CALF THYMUS; RNA;

EID: 0033526019     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00134-1     Document Type: Article

References (27)

1. 1. (a) Zamecnik, P. Antisense Nucleic Acid Drug Develop. 1997, 7, 199.
2. (b) Bennett, C. F. Biochem. Pharmacol. 1998, 55, 9.
3. 2. Torrence, P. F.; Xiao, W.; Li, G.; Lesiak, K.; Khamnei, S.; Maran, A.; Maitra, R.; Dong, B.; Silverman, R. H. in Carbohydrate Modifications in Antisense Research; Sanghvi, Y. S.; Cook, P. D., Eds; American Chemical Society: Washington, D. C., 1994; pp 119.
4. 3. (a) Gee, J. E.; Robbins, I.; van der Laan, A. C.; van Boom, J. H.; Colombier, C.; Leng, M.; Raible, A. M.; Nelson, J. S.; Lebleu, B. Antisense Nucleic Acid Drug Dev. 1998, 8, 103.
5. (b) Giles, R. V.; Spiller, D. G.; Tidd, D. M. Antisense Res. Dev. 1995, 5, 23.
6. (c) Crooke, S. T. Antisense Nucleic Acid Drug Dev. 1998, 8, 133.
7. 4. (a) Torrence, P. F.; Maitra, RK.; Lesiak, K.; Khamnei, S.; Zhou, A.; Silverman, R. H. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1300.
8. (b) Lesiak, K.; Khamnei, S.; Torrence, P. F. Bioconjugate Chem. 1993, 4, 467.
9. (c) Maran, A.; Maitra, R. K.; Kumar, A.; Dong, B.; Xiao, W.; Li, G.; Williams, B. R. G.; Torrence, P. F.; Silverman, R. H. Science 1994, 265, 789.
10. (d) Cirino, N. M.; Li, G.; Xiao, W.;. Torrence, P. F.; Silverman, R. H. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 1937.
11. (e) Player, M. R.; Barnard, DL.; Torrence, P. F. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 8874.
12. (f) Maran, A.; Waller, C. F.; Paranjape, J. M.; Li, G.; Xiao, W.; Zhang, K.; Kalaycio, M. E.; Maitra, R. K.; Lichtin, A. E.; Brugger, W.; Torrence, P. F.; Silverman, R. H. Blood 1998, 92, 4336.
13. (g) Kondo, S.; Kondo, Y.; Li, G.; Silverman, R. H.; Cowell, J. K. Oncogene 1998, 16, 3323.
14. 5. Player, M. R.; Torrence, P. F. Pharmacol. Ther. 1998, 78, 55.
15. 6. Crouch, R. J. New Biol. 1990, 2, 771.
16. 7. Dean, N. M.; Griffey, R. H. Antisense Nucleic Acid Drug. Dev. 1997, 7, 229.
17. 8. (a) Xiao, W.; Player, M. R.; Li, G.; Zhang, K.; Lesiak, K.; Torrence, P. F. Antisense Nucleic Acid Drug Devel. 1996, 6, 247.
18. (b) Li, G.; Xiao, W.; Torrence, P. F. J. Med. Chem. 1997, 40, 2959.
19. (c) Xiao, W.; Li, G.; Player, M. R.; Maitra, R. K.; Waller, C. F.; Silverman, R. H.; Torrence, P. F. J. Med. Chem. 1998, 41, 1531.
20. 9. Egli, M. Antisense Nucleic Acid Drug Dev. 1998, 8, 123.
21. 10. Xiao, W.; Li, G.; Maitra, R. K.; Maran, A.; Silverman, R. H.; Torrence, P. F. J. Med. Chem. 1997, 40, 1195.
22. 11. (a) Inoue, H.; Hayase, Y.; Iwai, S.; Ohtsuka, E. Nucleic Acids Res. Symp. Ser. 1987, 18, 221.
23. (b) Sproat, B. S.; Lamont, A. I. in Oligonucleotides and Analogues: A Practical Approach; Eckstein, F., Ed.; IRL Press: New York, NY, 1991; p 49.
24. 12. Hogrefe, H. H.; Hogrefe, R. I.; Walder, R. Y.; Walder, J. A. J. Biol. Chem. 1990, 265, 5561.
25. 13. (a) Player, M. R.; Wondrak E.; Bayly, S.; Torrence, P. F. Methods 1998, 15, 243.
26. (b) Dong, B.; Silverman, R.H. J. Biol. Chem. 1995, 270, 4133.
27. (c) Cole, J. L.; Carroll, S. S.; Kuo, L. C. J. Biol. Chem. 1996, 271, 3979.